ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

ACS To open Key Positions To Competition In Massive “Reorganization for the ‘90’s

August 6, 1993

Racker Withdraws Some Claims Made In Science Article, Says Data Are “No Question A Mess”

September 11, 1981

Cancer Advocates Use Benefit Analysis To Press For Funds

May 11, 1990

New Therapeutic Approaches Improve Palliative Care

June 27, 2003

Biomarker Identified Predicting Graft-Versus-Host Disease Risk

August 30, 2013

Sloan-Kettering Creates Paul Marks Award; Weinberg, Hong Honored By M. D. Anderson.

February 18, 2000